Greg Gille interviewed Ambienta managing partner and founder Nino Tronchetti Provera at the IPEM conference in Cannes on 23 January. Tronchetti Provera discussed where to find the most promising opportunities, and the way Ambienta goes about addressing concerns LPs might have had in the past about backing sustainability-focused strategies.
Held in Cannes over 22-24 January, IPEM gathered more than 1,900 industry participants to network and discuss the latest trends affecting the global private equity industry.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development